HCA Healthcare (NYSE:HCA) Updates FY 2025 Earnings Guidance

HCA Healthcare (NYSE:HCA) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 27.000-28.000 for the period, compared to the consensus estimate of 26.280. The company issued revenue guidance of $75.0 billion-$76.5 billion, compared to the consensus revenue estimate of $75.0 billion.

HCA Healthcare Price Performance

HCA stock opened at $440.07 on Friday. The company has a 50 day moving average price of $413.82 and a 200 day moving average price of $380.88. HCA Healthcare has a fifty-two week low of $289.98 and a fifty-two week high of $447.09. The stock has a market capitalization of $102.97 billion, a PE ratio of 18.50, a price-to-earnings-growth ratio of 1.39 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts expect that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on HCA shares. Truist Financial set a $460.00 price target on HCA Healthcare in a research report on Tuesday, October 14th. Royal Bank Of Canada cut their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research note on Monday, July 28th. Morgan Stanley cut their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research note on Monday, July 28th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Finally, Jefferies Financial Group increased their price target on shares of HCA Healthcare from $400.00 to $485.00 in a report on Wednesday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $437.19.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. MUFG Securities EMEA plc bought a new position in HCA Healthcare in the second quarter valued at approximately $196,000. Modern Wealth Management LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at $224,000. Sivia Capital Partners LLC boosted its holdings in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares in the last quarter. IHT Wealth Management LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at $271,000. Finally, Benjamin Edwards Inc. acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at $278,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.